Quince Therapeutics shares surge 10.07% intraday after hiring LifeSci Capital as exclusive financial advisor to restructure and evaluate strategic options including partnerships, mergers, or acquisitions.

Tuesday, Feb 24, 2026 10:42 am ET1min read
QNCX--
Quince Therapeutics surged 10.07% intraday as the company announced hiring LifeSci Capital as an exclusive financial advisor to assist with restructuring and evaluating strategic alternatives, including potential partnerships, joint ventures, mergers, or acquisitions, aiming to maximize shareholder value. The company specializes in leveraging patients' own biology to treat rare diseases, with its core product EryDex developed using the proprietary AIDE technology platform.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet